Itarnafloxin

N/A

Report date: 2022/11/25 17:42:46
NME

Base Information

Drug NameItarnafloxin
Drug Alias Name喹氟拉辛itarnafloxinumitarnafloxina伊他洛星itarnafloxine +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsRNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeuroendocrine TumorsLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCylene
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCylene Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeuroendocrine TumorsLymphoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A